LAUREN NYSTROM: Open Payments
NPI 1336398304 · NAPA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,048 in 90 payments from 17 companies in 2025. Trend: 2023 $2,288 · 2024 $3,026 · 2025 $2,048
Food & beverage: $1,897Education: $151
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $511 |
| Incyte Corporation | 21 | $441 |
| ABBVIE INC. | 9 | $207 |
| UCB, Inc. | 12 | $156 |
| Lilly USA, LLC | 9 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| GENZYME CORPORATION | 5 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $61 |
| Arcutis Biotherapeutics, Inc. | 2 | $48 |
Products named: TREMFYA, OPZELURA, SKYRIZI, Bimzelx, TALTZ, DUPIXENT, COSENTYX, SPEVIGO.
Industry payments across CA — which companies pay providers there.
